Global Expansion

Overview of Kitazato’s Global Business

Since its early years, Kitazato have proactively expanded into international markets to deliver products and technologies that contribute to the advancement of reproductive medicine worldwide.

Today, our products are used in more than 110 countries, primarily across Europe, Asia, Americas, and we have earned a global reputation as a leader in reproductive medicine.

Guided by our philosophy of contributing to the future of life, our international business is committed to providing optimal products and services while respecting the medical systems, regulations, and cultural values of every country we serve.

Key Features of Our Global Business

1. High-Quality Products Based on International Standards

Reproductive medicine requires exceptional levels of safety and reproducibility.
Accordingly, Kitazato Corporation has established quality management systems compliant with international medical device standards, including ISO 13485.

Our products conform to regulatory requirements in each market—such as CE marking, FDA submissions, and local regulatory approvals—ensuring they can be used with confidence in medical institutions worldwide.

2. Network of Local Distributors and Partners

We select reliable distributors and partners primarily in Europe, Asia, and North America, and work closely with them through education and technical support to build strong, trust-based relationships.

3. Utilization of Feedback from Global Markets

Insights, feedback, and clinical needs gathered from medical professionals around the world are actively shared with our development teams and reflected in product improvements and new product development.

4. Information Dissemination at International Conferences and Seminars

We actively share information at major international conferences such as ASRM and ESHRE, strengthening collaboration with researchers and healthcare professionals globally.

Regional Expansion (Examples)

Europe

• One of our key markets
• High quality requirements driven by the widespread adoption of advanced reproductive technologies
• Technical support systems established in collaboration with local distributors

Asia

• A rapidly growing region with strong demand for reproductive medicine
• Enhanced education and training programs for medical institutions
• High receptivity to new technologies

North America

• The world’s largest reproductive medicine market
• Robust quality assurance systems compliant with strict regulatory requirements
• Ongoing collaborative projects with research institutions

Value Created Through Global Operations

• Delivering advanced reproductive medical technologies to patients worldwide
• Enhancing product quality by applying insights gained from international markets
• Contributing to the development of global research and medical networks
• Advancing Japan-origin reproductive medical technologies toward global standards

Future Outlook

• Expansion of product lineups tailored to local regulations and medical environments
• Consideration of establishing local subsidiaries and support bases
• Globalization of research and development and clinical data collection
• Creation of innovative technologies through international collaboration
• Construction of a sustainable global supply chain

Kitazato Corporation will continue to provide optimal products and services
for medical professionals and patients around the world.